Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Correction to: Comparative analysis of confocal microscopy on fresh breast core needle biopsies and conventional histology.

Elfgen C, Papassotiropoulos B, Varga Z, Moskovszky L, Nap M, Güth U, Baege A, Amann E, Chiesa F, Tausch C.

Diagn Pathol. 2019 Aug 8;14(1):87. doi: 10.1186/s13000-019-0861-x.

2.

Prognostic impact of PIK3CA protein expression in triple negative breast cancer and its subtypes.

Elfgen C, Reeve K, Moskovszky L, Güth U, Bjelic-Radisic V, Fleisch M, Tausch C, Varga Z.

J Cancer Res Clin Oncol. 2019 Aug;145(8):2051-2059. doi: 10.1007/s00432-019-02968-2. Epub 2019 Jul 3.

PMID:
31270600
3.

Comparative analysis of confocal microscopy on fresh breast core needle biopsies and conventional histology.

Elfgen C, Papassotiropoulos B, Varga Z, Moskovszky L, Nap M, Güth U, Baege A, Amann E, Chiesa F, Tausch C.

Diagn Pathol. 2019 Jun 15;14(1):58. doi: 10.1186/s13000-019-0835-z. Erratum in: Diagn Pathol. 2019 Aug 8;14(1):87.

4.

The impact of distinct triple-negative breast cancer subtypes on misdiagnosis and diagnostic delay.

Elfgen C, Varga Z, Reeve K, Moskovszky L, Bjelic-Radisic V, Tausch C, Güth U.

Breast Cancer Res Treat. 2019 Aug;177(1):67-75. doi: 10.1007/s10549-019-05298-6. Epub 2019 Jun 1.

PMID:
31154578
5.

Prospective Evaluation of Residual Breast Tissue After Skin- or Nipple-Sparing Mastectomy: Results of the SKINI-Trial.

Papassotiropoulos B, Güth U, Chiesa F, Rageth C, Amann E, Baege A, Elfgen C, Varga Z, Moskovszky L, Endhardt K, Masser R, Tinguely M, Farhadi J, Lardi A, Dammann F, Diebold J, Li Q, Dubsky P, Tausch C.

Ann Surg Oncol. 2019 May;26(5):1254-1262. doi: 10.1245/s10434-019-07259-1. Epub 2019 Mar 4.

PMID:
30830538
6.

Primary urethral squamous cell carcinoma: a unique manifestation of a penile tumor.

Antwerpen I, Gstrein L, Moskovszky L, Gissler HM, Möltgen T, Kwiatkowski M, Wyler S, Walter M.

J Int Med Res. 2019 Feb;47(2):999-1004. doi: 10.1177/0300060518813506. Epub 2018 Dec 5.

7.

Preferential expression of NY-BR-1 and GATA-3 in male breast cancer.

Biserni GB, Di Oto E, Moskovszky LE, Foschini MP, Varga Z.

J Cancer Res Clin Oncol. 2018 Feb;144(2):199-204. doi: 10.1007/s00432-017-2542-z. Epub 2017 Nov 7.

8.

CD8+/FOXP3+-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study.

Fritzsching B, Fellenberg J, Moskovszky L, Sápi Z, Krenacs T, Machado I, Poeschl J, Lehner B, Szendrõi M, Bosch AL, Bernd L, Csóka M, Mechtersheimer G, Ewerbeck V, Kinscherf R, Kunz P.

Oncoimmunology. 2015 Apr 2;4(3):e990800. eCollection 2015 Mar.

9.

Improved survival in osteosarcoma patients with atypical low vascularization.

Kunz P, Fellenberg J, Moskovszky L, Sápi Z, Krenacs T, Machado I, Poeschl J, Lehner B, Szendrõi M, Ruef P, Bohlmann M, Bosch AL, Ewerbeck V, Kinscherf R, Fritzsching B.

Ann Surg Oncol. 2015 Feb;22(2):489-96. doi: 10.1245/s10434-014-4001-2. Epub 2014 Aug 26.

PMID:
25155396
10.

Osteosarcoma microenvironment: whole-slide imaging and optimized antigen detection overcome major limitations in immunohistochemical quantification.

Kunz P, Fellenberg J, Moskovszky L, Sápi Z, Krenacs T, Poeschl J, Lehner B, Szendrõi M, Ewerbeck V, Kinscherf R, Fritzsching B.

PLoS One. 2014 Mar 3;9(3):e90727. doi: 10.1371/journal.pone.0090727. eCollection 2014.

11.

Analysis of giant cell tumour of bone cells for Noonan syndrome/cherubism-related mutations.

Moskovszky L, Idowu B, Taylor R, Mertens F, Athanasou N, Flanagan A.

J Oral Pathol Med. 2013 Jan;42(1):95-8. doi: 10.1111/j.1600-0714.2012.01194.x. Epub 2012 Jun 22.

PMID:
22725657
12.

Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of bone.

Balla P, Moskovszky L, Sapi Z, Forsyth R, Knowles H, Athanasou NA, Szendroi M, Kopper L, Rajnai H, Pinter F, Petak I, Benassi MS, Picci P, Conti A, Krenacs T.

Histopathology. 2011 Sep;59(3):376-89. doi: 10.1111/j.1365-2559.2011.03948.x.

PMID:
22034878
13.

The activated targets of mTOR signaling pathway are characteristic for PDGFRA mutant and wild-type rather than KIT mutant GISTs.

Sápi Z, Füle T, Hajdu M, Matolcsy A, Moskovszky L, Márk A, Sebestyén A, Bodoky G.

Diagn Mol Pathol. 2011 Mar;20(1):22-33. doi: 10.1097/PDM.0b013e3181eb931b.

PMID:
21326036
14.

Centrosome abnormalities in giant cell tumour of bone: possible association with chromosomal instability.

Moskovszky L, Dezsö K, Athanasou N, Szendröi M, Kopper L, Kliskey K, Picci P, Sápi Z.

Mod Pathol. 2010 Mar;23(3):359-66. doi: 10.1038/modpathol.2009.134. Epub 2010 Jan 8.

15.

Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analysis.

Moskovszky L, Szuhai K, Krenács T, Hogendoorn PC, Szendroi M, Benassi MS, Kopper L, Füle T, Sápi Z.

Genes Chromosomes Cancer. 2009 Jun;48(6):468-79. doi: 10.1002/gcc.20656.

PMID:
19242928

Supplemental Content

Loading ...
Support Center